Serum Anti-Mullerian Hormone Levels in Normoovulatory and Anovulatory Women with Polycystic Ovaries: Relationship to the Ovarian Follicular Arrest

Jie Qiao,Jinliang Li,S. Zhao,X. Zhang
DOI: https://doi.org/10.1016/j.fertnstert.2008.07.1595
IF: 6.7
2008-01-01
Fertility and Sterility
Abstract:OBJECTIVE: To compare serum and follicular fluid (FF) AMH levels in normoovulatory and anovulatory women with PCO and evaluate the relationship between AMH and the follicular arrest of the infertile women with PCO. DESIGN: Case-control study. MATERIALS AND METHODS: Thirty-five normoovulatory women with normal ovarian morphology (group A, control), 29 normoovulatory women with PCO (group B) and 38 anovulatory women with PCO (group C) underwent controlled ovarian hyperstimulation (COH) with the short protocol. Serum AMH levers on the day 0 and 6 of gonadotropins treatment (d0 or d6) and the day of HCG administration (dHCG) were measured using enzyme-linked immunosorbent assay (ELISA). FF AMH levels on the day of oocyte pickup (dOPU) were measured using same method as serum assay. RESULTS: No significant difference in serum AMH levels of d0, d6 and dHCG during COH was found between group B and C (5.87 vs. 7.99, 3.92 vs. 5.54, and 2.45 vs. 2.90ng/ml, respectively; P>0.05), but significantly higher than group A. (2.52, 1.17, and 0.79ng/ml, respectively; P<0.01). FF AMH levels have no difference between group B and C (54.77 vs. 64.05ng/g protein; P>0.05), but significantly higher than group A (29.45 ng/g protein; P<0.05). Significant correlation was found between serum AMH (d0, d6 or dHCG) and follicle numbers (d0 or dOPU).Table 1Serum and FF AMH levels during COH (median and range)timeGroup A (n=35)Group B (n=29)Group C (n=38)serum AMH levels (ng/ml)d02.52 (0.22-10.80)5.87 (2.34-15.60)bcompared with group A, P<0.01.7.99 (3.13-14.80)acompared with group A, P<0.001.d81.17 (0.10-5.53)3.92 (1.14-13.10)acompared with group A, P<0.001.5.54 (1.84-11.70)acompared with group A, P<0.001.dHCG0.79 (0.03-2.88)2.45 (0.67-9.23)acompared with group A, P<0.001.2.90 (1.13-7.00)acompared with group A, P<0.001.FF AMH levels (ng/g protein)dOPU29.45 (8.1-160.9)54.77 (22.3-203.3)ccompared with group A, P<0.05.64.05 (19.6-281)bcompared with group A, P<0.01.Group A= normoovulatory women with normal ovarian morphology; Group B= normoovulatory women with PCO;Group C= anovulatory women with PCO.a compared with group A, P<0.001.b compared with group A, P<0.01.c compared with group A, P<0.05. Open table in a new tab Group A= normoovulatory women with normal ovarian morphology; Group B= normoovulatory women with PCO;Group C= anovulatory women with PCO. CONCLUSIONS: Serum and FF AMH levels increase in PCO group suggest that AMH secreted by granulose cells may increase. No significant difference in serum and FF AMH in normoovulatory and anovulatory women with PCO suggest that an increased AMH level may not result in the follicular arrest. Serum AMH levels during COH may be used as a marker for the quantitative aspect of ovarian reserve and ovarian response.
What problem does this paper attempt to address?